No Data
RAINMED-B (02297) announced its annual performance, with a loss attributable to Shareholders of 0.114 billion, a 2% year-on-year reduction.
RAINMED-B (02297) announced its annual performance for the year ending December 31, 2024, during which the group achieved a...
Express News | Rainmed Medical FY Gross Profit RMB 23.9 Million
Express News | Rainmed Medical FY Gross Margin 60.1%
RAINMED-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
RAINMED-B (02297.HK) held a Board of Directors meeting on March 31 to consider and approve the annual performance.
Globe News reported on March 19 that RAINMED-B (02297.HK) announced that the Board of Directors will hold a meeting on March 31, 2025 (Monday) to consider and approve the annual performance of the company and its subsidiaries for the period ending December 31, 2024, and to publish it, as well as to consider the distribution of a final dividend (if any), and to address Other matters.
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
